首页> 美国卫生研究院文献>BMC Infectious Diseases >A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol
【2h】

A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol

机译:一项前瞻性队列研究用于评估免疫抑制细胞因子作为预测感染HR-HPV的妇女宫颈中的病毒持续性和进展为恶变前病变的指标:研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCervical cancer (CC) is caused by a persistent infection of high-risk human papillomavirus (HR-HPV). While most HPV infections are transient, persistent HPV infections are a significant health problem in Mexico. With an estimated HPV prevalence of 10% among women in reproductive age, approximately 25% of these women present at least a positive result in triage test, which according to previous studies is expected to be confirmed as positive CIN-2/3. The immune system has a key role in the natural history of HPV infection; alterations in the cellular immune response are responsible for the failure to eliminate HPV. The objective of this project is to assess the prognostic value of detecting immune markers (IL-10, IL-4, TGFβ1, IFNγ, IL-6, and TNFα), the expression of HPV-HR E6/E7 proteins, and the viral load at the cervical level with respect to the persistence or clearance of HR-HPV infection, and the regression or progression of a cervical premalignant lesion.
机译:背景宫颈癌(CC)是由持续感染高危型人乳头瘤病毒(HR-HPV)引起的。尽管大多数HPV感染是暂时性的,但在墨西哥,持续性HPV感染是一个重大的健康问题。据估计,育龄妇女的HPV患病率为10%,这些妇女中约25%的分流测试至少显示阳性结果,根据先前的研究,该结果有望被确认为CIN-2 / 3阳性。免疫系统在HPV感染的自然史中起着关键作用。细胞免疫反应的改变是导致无法消除HPV的原因。该项目的目的是评估检测免疫标记(IL-10,IL-4,TGFβ1,IFNγ,IL-6和TNFα),HPV-HR E6 / E7蛋白的表达和病毒的预后价值。与HR-HPV感染的持久性或清除率以及宫颈癌前病变的消退或进展有关的宫颈负荷。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号